HCPLive

JANUARY 1, 2025

Patients hospitalized for severe COVID-19 had an accelerated eGFR decline relative to those with pneumonia due to other infections.

COVID-19 105

COVID-19 Hospital 105

Nature Reviews - Cardiology

JANUARY 1, 2025

Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01104-z Endovascular renal denervation has been approved for the treatment of hypertension. In this Review, Fisher and Kirtane discuss the clinical trial data on its efficacy and safety and provide practical guidance on patient selection and clinical implementation of the procedure.

Hypertension 89

Hypertension 89

The New England Journal of Medicine

JANUARY 1, 2025

A randomized trial of the factor XIa inhibitor asundexian was stopped early owing to a higher incidence of stroke or systemic embolism than with apixaban therapy among patients with atrial fibrillation.

Atrial Fibrillation 75

Atrial Fibrillation Embolism Stroke Strokes 75

Nature Reviews - Cardiology

JANUARY 1, 2025

Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01109-8 In this Review, Lavine and colleagues describe the known subsets of cardiac macrophages, highlighting newly identified macrophage states and associated cellular neighbourhoods, and discuss the roles of cardiac macrophages in homeostasis and disease, including in inflammation, fibrosis, age-associated pathologies, mechanosensing, efferocytosis, angiogenesis, arrhythmias and transplant allograft survival.

Transplant 78

Transplant Arrhythmia 78

The New England Journal of Medicine

JANUARY 1, 2025

Among patients with transthyretin amyloidosis with cardiomyopathy, the risk of death from any cause and recurrent cardiovascular events was lower with vutrisiran treatment than with placebo.

Cardiomyopathy 74

Cardiomyopathy 74

Nature Reviews - Cardiology

JANUARY 1, 2025

Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01111-0 In this Review, Born and colleagues present insights into the role of apolipoprotein B-containing lipoproteins in atherogenesis, with an emphasis on the mechanisms leading to atherosclerotic plaque initiation and growth. They describe the causative role of LDL at the early stages of atherogenesis and discuss the relative atherogenicity of lipoprotein(a) and triglyceride-rich lipoproteins.

Plaque 97

Plaque 97

Cardiovascular Diabetology

JANUARY 1, 2025

Adipose tissue distribution plays a crucial role in the development of cardiovascular complications. In particular, visceral adipose tissue (VAT) has been linked to insulin resistance (IR) and cardiovascular d.

59

59

HCPLive

JANUARY 1, 2025

Rani discussed an in-depth study examining quality of sleep and quality of life in children and adolescents with SCD.

Quality of Life 59

Quality of Life 59

Nature Reviews - Cardiology

JANUARY 1, 2025

Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01114-x In this Review, Heusch and Kleinbongard describe the deleterious and protective roles of the spleen in the inflammatory processes of atherosclerosis, myocardial infarction and heart failure, and highlight the translational potential of the cardioprotective functions of the spleen for the treatment of patients with ischaemic heart disease.

Heart Disease 98

Heart Disease Myocardial Infarction Atherosclerosis Heart Failure 98

The New England Journal of Medicine

JANUARY 1, 2025

The survival of patients with the two most prevalent forms of systemic amyloidosis light chain amyloidosis, which is caused by aggregates of monoclonal immunoglobulin light chains, and transthyretin amyloidosis (ATTR amyloidosis), which is caused by aggregates of wild-type or variant transthyretin is determined largely by cardiac involvement. Therapy.

Cardiomyopathy 58

Cardiomyopathy 58

Nature Reviews - Cardiology

JANUARY 1, 2025

Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01103-0 Vascular cells are finely regulated by complex microenvironments, including biomechanical signals from the extracellular matrix. In this Review, Kong and colleagues describe the role of the extracellular matrix in vascular development, ageing and disease, and highlight the potential of novel therapies targeting this fine-tuned network.

59

59

Dr. Paddy Barrett

JANUARY 1, 2025

The Heart Health Formula is everything you need to address your risk of heart disease. If you are looking to: Lower high cholesterol. Lower high blood pressure. Lose visceral fat. Assess for genetic risks of heart disease. Understand what tests best define risk. And much more. The Heart Health Formula has these covered and so much more. In addition to the 9 hours of content covering these topics, the Heart Health Formula comes with two free bonuses.

Blood Pressure 60

Blood Pressure Heart Disease Cholesterol 60

Nature Reviews - Cardiology

JANUARY 1, 2025

Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01108-9 In this Review, Yvan-Charvet and colleagues discuss how cardiovascular risk factors and metabolic modifiers of atherosclerosis influence metabolism-dependent haematopoietic stem cell skewing (haematometabolism) and efferocyte reprogramming (efferotabolism) and highlight potential therapeutic strategies to reduce the risk of atherosclerosis by rebalancing haematopoiesis and efferocytosis.

Cardiovascular Disease 81

Cardiovascular Disease Atherosclerosis Risk Factors 81

Cardiovascular Diabetology

JANUARY 1, 2025

The analyses of longitudinal changes in remnant cholesterol (RC) and cardiovascular disease (CVD) remains are limited. The objective of the study was to investigate the associations of longitudinal changes in.

52

52

Frontiers in Cardiovascular Medicine

JANUARY 1, 2025

BackgroundAtrial fibrillation (AF) is a prevalent cardiac arrhythmia, with ventricular rate control being a critical therapeutic target. However, the optimal range for ventricular rate control remains unclear. Additionally, the relationship between different levels of ventricular rate control and cardiac remodeling in patients with atrial fibrillation remains unclear.ObjectiveThis study aims to explore the relationship between different levels of heart rate control and cardiac remodeling in pati

Atrial Fibrillation 52

Atrial Fibrillation Bicuspid/Mitral Coronary Artery Disease BMI 52

Cardiovascular Diabetology

JANUARY 1, 2025

Prior studies have demonstrated an association between retinal vascular features and cardiovascular disease (CVD), however most studies have only evaluated a few simple parameters at a time. Our aim was to det.

52

52

HCPLive

JANUARY 1, 2025

A list recapping our most popular endocrinology coverage from the past year.

52

52

Dr. S. Venkatesan MD

JANUARY 1, 2025

Welcome to 2025 and best wishes for a great academic journey to all readers. Collected from ACC website (Arranged in three heading) These are the creamy academic extract of whatever happened over the last one year. Thanks to ACC for compiling it. While the first one,(Trials) will be under scrutiny, the other two , ie the cardiology news stories and magazine reviews are absolute gem of learning resource.

Cardiogenic Shock 59

Cardiogenic Shock Plaque Academic Bicuspid/Mitral 59

HCPLive

JANUARY 1, 2025

Panelists discuss how proper blood pressure measurement techniques require careful attention to patient positioning, cuff size selection, and standardized procedures to ensure accurate readings.

Blood Pressure 52

Blood Pressure 52

European Journal of Cardiovascular Nursing

JANUARY 1, 2025

Abstract The participatory co-design method has received significant attention recently. Experience-based co-design is an approach that enables patients (service users) and healthcare providers (service delivers) to co-design services and care pathways in partnership to improve health outcomes based on their experience. Traditionally, it was used as a quality improvement technique.

Chronic Disease 40

Chronic Disease Research Nursing Outcomes 40

HCPLive

JANUARY 1, 2025

Panelists discuss how evaluating uncontrolled hypertension in patients with early kidney dysfunction requires a careful investigation of underlying causes, including medication adherence, lifestyle factors, and potential secondary hypertension.

Hypertension 52

Hypertension 52

HeartRhythm

JANUARY 1, 2025

Dual antiplatelet therapy and oral anticoagulation in combination with aspirin represent recommended treatment regimens after left atrial appendage closure (LAAC). As most patients receiving LAAC have high bleeding risk, less aggressive antithrombotic treatments are needed, such as single antiplatelet therapy.

40

40

The American Journal of Cardiology

JANUARY 1, 2025

Publication date: Available online 31 December 2024 Source: The American Journal of Cardiology Author(s): Takuma Takada, Eiji Shibahashi, Shun Hasegawa, Ayano Yoshida, Makoto Kishihara, Shonosuke Watanabe, Shota Shirotani, Takuro Abe, Masashi Nakao, Junichi Yamaguchi, Kentaro Jujo

Ischemia 40

Ischemia Heart Failure 40

European Journal of Cardiovascular Nursing

JANUARY 1, 2025

Abstract Aims Improved dietary habits are important for successful secondary prevention after myocardial infarction (MI), with counselling and support on healthy dietary habits constituting a cornerstone of cardiac rehabilitation (CR). However, there is limited knowledge on how to optimize CR organization to motivate patients to adopt healthy dietary habits.

Cardiac Rehabilitation 40

Cardiac Rehabilitation Myocardial Infarction Nursing Risk Factors 40

The American Journal of Cardiology

JANUARY 1, 2025

Publication date: Available online 31 December 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Abhishek Singh, Ritika Kompella, Anindita Chanda, Chirag Mehta, Christopher J Mullin, J Dawn Abbott, Saraschandra Vallabhajosyula

Embolism 40

Embolism Pulmonary Hospital Outcomes 40